500 mg lyophilized powder for concentrate for solution for I.V. infusion glass vial №1
Concentration
Excipients
Manufacturing site GMP status
Spanish Agency of Medicines and Medical Devices (AEMPS) Certificate No.: NCF_2578-001
US FDA establishment registration (FEI; registration is not an FDA approval)
3003877289
API manufacturing site GMP status
FDA and ANVISA GMP (Brazil) Certified API manufacturer
Additional GMP certification
Certified by ANVISA (Brazil) under PIC/S GMP standards for API
Therapeutic Area
Oncology
Country of manufacture
Manufacturing site country
Spain
Additional Information
No items found.
Prescription-only medicine. This information is intended for healthcare professionals and prospective business partners. It is not promotional material and is not intended for patients. For approved product information, consult the Georgian medicines register or contact us. To report a suspected side effect from a medicine supplied by Mermisi, please contact us.
.png)